Los Angeles Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.8M Sell
131,751
-3,715,117
-97% -$429M 0.06% 207
2025
Q4
$332M Buy
3,846,868
+434,420
+13% +$40.8M 1.13% 14
2025
Q3
$286M Buy
3,412,448
+956,879
+39% +$78.8M 0.97% 14
2025
Q2
$194M Sell
2,455,569
-219,276
-8% -$17.4M 0.73% 25
2025
Q1
$240M Buy
2,674,845
+1,305,255
+95% +$122M 1.06% 17
2024
Q4
$136M Sell
1,369,590
-1,335,530
-49% -$138M 0.55% 39
2024
Q3
$307M Sell
2,705,120
-102,813
-4% -$12.2M 1.24% 10
2024
Q2
$348M Buy
2,807,933
+1,959,152
+231% +$252M 1.24% 10
2024
Q1
$112M Buy
848,781
+472,479
+126% +$58.2M 0.38% 59
2023
Q4
$41M Buy
376,302
+92,146
+32% +$9.56M 0.15% 125
2023
Q3
$29.3M Sell
284,156
-223,038
-44% -$24M 0.12% 155
2023
Q2
$58.5M Sell
507,194
-26,184
-5% -$2.97M 0.23% 84
2023
Q1
$56.7M Sell
533,378
-275,642
-34% -$29.8M 0.25% 90
2022
Q4
$89.8M Buy
809,020
+85,594
+12% +$8.75M 0.44% 57
2022
Q3
$62.3M Buy
723,426
+51,258
+8% +$4.58M 0.32% 77
2022
Q2
$61.3M Sell
672,168
-63,713
-9% -$5.65M 0.3% 80
2022
Q1
$60.4M Buy
735,881
+7,398
+1% +$583K 0.24% 99
2021
Q4
$55.8M Buy
728,483
+294,056
+68% +$23.4M 0.21% 103
2021
Q3
$32.6M Sell
434,427
-239,364
-36% -$18.2M 0.15% 131
2021
Q2
$52.4M Sell
673,791
-255,858
-28% -$19M 0.23% 100
2021
Q1
$68.4M Sell
929,649
-462,067
-33% -$34.1M 0.31% 75
2020
Q4
$109M Sell
1,391,716
-48,572
-3% -$3.71M 0.46% 40
2020
Q3
$114M Sell
1,440,288
-630,823
-30% -$49.4M 0.52% 36
2020
Q2
$153M Sell
2,071,111
-118,749
-5% -$8.94M 0.74% 22
2020
Q1
$161M Buy
2,189,860
+199,167
+10% +$15.7M 1.02% 14
2019
Q4
$173M Buy
1,990,693
+106,003
+6% +$8.71M 0.86% 14
2019
Q3
$151M Buy
1,884,690
+657,740
+54% +$52.7M 0.82% 18
2019
Q2
$98.2M Buy
1,226,950
+534,676
+77% +$40.9M 0.53% 37
2019
Q1
$54.9M Sell
692,274
-428,929
-38% -$32.1M 0.31% 77
2018
Q4
$81.7M Buy
1,121,203
+100,976
+10% +$7.13M 0.51% 43
2018
Q3
$69.1M Buy
1,020,227
+261,969
+35% +$16.7M 0.36% 57
2018
Q2
$43.9M Sell
758,258
-113,053
-13% -$6.38M 0.24% 104
2018
Q1
$45.3M Sell
871,311
-652,559
-43% -$35.2M 0.26% 107
2017
Q4
$81.8M Sell
1,523,870
-85,749
-5% -$4.75M 0.45% 47
2017
Q3
$98.3M Buy
1,609,619
+155,742
+11% +$9.44M 0.57% 30
2017
Q2
$88.9M Buy
1,453,877
+40,186
+3% +$2.45M 0.56% 30
2017
Q1
$85.7M Sell
1,413,691
-671,278
-32% -$40.7M 0.62% 26
2016
Q4
$117M Sell
2,084,969
-480,054
-19% -$28.1M 0.92% 14
2016
Q3
$153M Sell
2,565,023
-18,853
-0.7% -$1.1M 1.27% 6
2016
Q2
$142M Buy
2,583,876
+185,587
+8% +$9.88M 1.2% 7
2016
Q1
$121M Buy
2,398,289
+1,712,436
+250% +$83.9M 1.08% 15
2015
Q4
$34.6M Buy
685,853
+85,188
+14% +$4.3M 0.32% 88
2015
Q3
$28.3M Sell
600,665
-37,787
-6% -$2.01M 0.28% 106
2015
Q2
$34.7M Sell
638,452
-254,691
-29% -$14.3M 0.32% 89
2015
Q1
$49M Sell
893,143
-889,253
-50% -$50.4M 0.45% 54
2014
Q4
$96.6M Buy
1,782,396
+327,338
+22% +$18.2M 0.89% 19
2014
Q3
$82.3M Buy
1,455,058
+512,465
+54% +$28.8M 0.99% 13
2014
Q2
$52M Buy
942,593
+117,043
+14% +$6.39M 0.5% 44
2014
Q1
$44.7M Sell
825,550
-131,681
-14% -$6.82M 0.49% 49
2013
Q4
$45.7M Sell
957,231
-333,125
-26% -$15.2M 0.51% 42
2013
Q3
$58.6M Sell
1,290,356
-105,959
-8% -$4.84M 0.72% 19
2013
Q2
$61.9M Buy
+1,396,315
New +$62.4M 0.88% 19

Other funds holding MRK

Los Angeles Capital Management's MRK Position: Q1 2026 in Review

Los Angeles Capital Management reduced its Merck (MRK) stake by 97% in Q1 2026, selling an estimated $429M and leaving 131,751 shares worth $15.8M. The position accounts for 0.06% of the portfolio, ranked #207.

Los Angeles Capital Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $348M in Q2 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Los Angeles Capital Management held 131,751 shares of Merck worth $15.8M as of Q1 2026.
  • Los Angeles Capital Management sold 3,715,117 Merck shares in Q1 2026, an estimated $429M.
  • Merck made up 0.06% of Los Angeles Capital Management's portfolio in Q1 2026, its #207 holding.
  • Los Angeles Capital Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Los Angeles Capital Management's Merck position peaked at $348M in Q2 2024.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.